A compound of general formula (I) or pharmaceutically acceptable salts, hydrates, solvates, crystal forms of diastereomers thereof is described. A method of treating protein kinase-associated disease states using the compound of Formula (I) is also described.
描述了一种具有一般式(I)或药用可接受的盐、
水合物、溶剂化合物、晶体形式或其不对映异构体的化合物。还描述了使用式(I)化合物治疗蛋白激酶相关疾病状态的方法。